OTCMKTS:MEDH

MedX Stock Forecast, Price & News

$0.0094
0.00 (-6.93 %)
(As of 04/20/2021 05:19 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.07
Volume3.72 million shs
Average Volume9.69 million shs
Market Capitalization$1.35 million
P/E RatioN/A
Dividend YieldN/A
Beta3.52
MedX Holdings, Inc., a development stage company, engages in the research and development of Wearable Technology Heat. It also acquires various medical businesses through its Collaborative Profit concept. The company was formerly known as Cantor Group Inc. and changed its name to MedX Holdings, Inc. in February 2016. MedX Holdings, Inc. was founded in 2006 and is based in Cheyenne, Wyoming.
MedX logo

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MEDH
CUSIPN/A
CIKN/A
Phone877-225-0243
Employees1
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$1.35 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1997th out of 2,018 stocks

Business Services, Not Elsewhere Classified Industry

188th out of 192 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0094
0.00 (-6.93 %)
(As of 04/20/2021 05:19 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MEDH News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedX (OTCMKTS:MEDH) Frequently Asked Questions

What stocks does MarketBeat like better than MedX?

Wall Street analysts have given MedX a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedX wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MedX?

MedX saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 164,700 shares, an increase of 243.8% from the March 15th total of 47,900 shares. Based on an average daily trading volume, of 13,538,100 shares, the short-interest ratio is presently 0.0 days.
View MedX's Short Interest
.

Who are MedX's key executives?

MedX's management team includes the following people:
  • Mr. Hans Enriquez, CEO, Pres & Director
  • Ms. Lori Frisher, VP of Marketing & Bus. Devel. (Age 48)
  • Mr. Harry Brumleve, VP of Engineering

Who are some of MedX's key competitors?

What is MedX's stock symbol?

MedX trades on the OTCMKTS under the ticker symbol "MEDH."

How do I buy shares of MedX?

Shares of MEDH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MedX's stock price today?

One share of MEDH stock can currently be purchased for approximately $0.01.

How much money does MedX make?

MedX has a market capitalization of $1.35 million.

How many employees does MedX have?

MedX employs 1 workers across the globe.

What is MedX's official website?

The official website for MedX is www.medxpharmaceuticals.com.

Where are MedX's headquarters?

MedX is headquartered at 7730 E. BELLEVIEW AVENUE SUITE A-306, GREENWOOD VILLAGE CO, 80111.

How can I contact MedX?

MedX's mailing address is 7730 E. BELLEVIEW AVENUE SUITE A-306, GREENWOOD VILLAGE CO, 80111. The company can be reached via phone at 877-225-0243 or via email at [email protected]


This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.